Bloomberg
Arbutus Biopharma Corp. convinced a federal judge in Delaware to mostly adopt its proposed definitions of three disputed claims in six vaccine-delivery patents it alleges Moderna Inc.’s Covid-19 shot infringes.
Judge Mitchell S. Goldberg, in an opinion issued Wednesday in the US District Court for the District of Delaware, agreed with Arbutus and co-plaintiff Genevant Sciences GmbH’s proposed construction of a claim that appears in five of the patents. The claim is related to the specific percentage of lipids—fat-like molecules—that are present in a tiny particle used for delivering genetic material like mRNA into cells.
Read more
https://news.bloomberglaw.com/ip-law/arbutus-wins-patent-claims-ruling-in-moderna-covid-vaccine-case
